Chapter 20. The Role of RARα and Its Fusion Partners in Acute Promyelocytic Leukemia
- Katya Ravid2,
- Jonathan D. Licht3
Published Online: 19 MAR 2002
DOI: 10.1002/0471223883.ch20
Copyright © 2001 by Wiley-Liss, Inc.
Book Title

Transcription Factors: Normal and Malignant Development of Blood Cells
Additional Information
How to Cite
Melnick, A. and Licht, J. D. (2002) The Role of RARα and Its Fusion Partners in Acute Promyelocytic Leukemia, in Transcription Factors: Normal and Malignant Development of Blood Cells (eds K. Ravid and J. D. Licht), John Wiley & Sons, Inc., New York, USA. doi: 10.1002/0471223883.ch20
Editor Information
- 2
Department of Biochemistry, Boston University School of Medicine, Boston, MA
- 3
Derald H. Ruttenberg Cancer Center and Department of Medicine, Mount Sinai School of Medicine, New York, NY
Publication History
- Published Online: 19 MAR 2002
- Published Print: 15 DEC 2000
ISBN Information
Print ISBN: 9780471350545
Online ISBN: 9780471223887
- Summary
- Chapter
Keywords:
- retinoic acid receptor alpha (RARα);
- transcriptional function;
- myeloid differentiation;
- target genes;
- acute promyelocytic leukemia (APL);
- PML-RARα;
- promyelocytic leukemia zinc finger (PLZF);
- PLZF-RARα;
- RARα-PLZF;
- nucleophosmin;
- NPM-RARα;
- NuMA-RARα;
- STAT5b-RARα
Summary
Acute promyelocytic leukemia (APL) is now associated with five different gene rearrangements, fusing retinoic acid receptor alpha (RARα) to the promyelocytic leukemia (PML) gene, promyelocytic leukemia zinc finger (PLZF), nucleophosmin (NPM), nuclear matrix-associated (NuMA) and STAT5b genes, leading to the formation of reciprocal fusion proteins (N-RARα and RARα-N). Disruption of both RAR and the partner gene function may both play roles in the pathogenesis of the disease.
